National Trends and Disparities in Mortality Involving Coexisting Cirrhosis/Hepatic Fibrosis and Sepsis Among U.S. Adults, 1999–2024
This study reveals that mortality involving coexisting cirrhosis or hepatic fibrosis and sepsis among U.S. adults aged 25 and older significantly increased from 1999 to 2024, with pronounced disparities observed across age, race, geography, and urbanization status.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human liver is a tireless internal chemist, filtering toxins, storing energy, and managing the body's immune defenses. When this organ is damaged by chronic disease, it can harden and scar, a condition known as cirrhosis. This scarring disrupts the liver's ability to function and, crucially, weakens the body's natural defenses against infection. When a severe infection takes hold, it can spiral into sepsis, a life-threatening state where the body's response to the infection damages its own tissues and organs. For a person with a healthy liver, a severe infection is a serious medical event; for someone with advanced liver scarring, the combination of a weakened immune system and a failing organ often creates a perfect storm that is extremely difficult to survive. Understanding how often these two conditions occur together and how that risk has changed over time is vital for public health, as it reveals where the most vulnerable people are and whether current medical systems are keeping pace with the growing threat.
A new national study has mapped the landscape of this deadly combination across the United States over the last quarter-century. Researchers examined death records from 1999 through 2024 to track every instance where a person died with both liver scarring and sepsis listed on their certificate. They found that while this specific type of death was relatively rare at the start of the study, it has become significantly more common. The rate of these deaths rose from 1.7 per 100,000 people in 1999 to 4.0 per 100,000 in 2024. This increase was not a straight, steady line; the numbers held relatively steady for the first decade, then began to climb sharply between 2009 and 2021, before leveling off slightly in the most recent years. The study suggests that the burden of this dual threat has grown substantially, becoming a more pressing issue for the nation's health infrastructure.
The data reveals that this rising risk is not felt equally by everyone. The danger is highest for older adults, particularly those over 65, and for men, who consistently face higher death rates than women. However, the speed of the increase tells a different story for some groups. While men have higher absolute numbers, the rate of increase has been faster for women. The study also highlights a stark geographic divide. People living in rural areas, far from major cities, now face a higher risk of dying from this combination than those in metropolitan centers, a reversal of the pattern seen in the early years of the study. Furthermore, certain regions of the country, particularly the West, and specific populations, such as American Indian and Alaska Native communities, carry a much heavier burden of these deaths compared to the national average.
The researchers looked closely at the timing of these trends to understand what might be driving them. The sharp rise that began around 2009 coincides with broader national increases in liver disease, while the acceleration during the pandemic years likely reflects a mix of delayed medical care, increased alcohol-related harm, and the direct effects of viral infections on an already compromised system. The study does not claim to prove exactly why these specific groups are dying at higher rates, but it points to a convergence of factors: an aging population, the growing prevalence of metabolic and alcohol-related liver disease, and persistent gaps in access to specialized medical care in rural and underserved areas. The findings suggest that the current system is struggling to protect the most vulnerable, particularly those in remote communities and specific demographic groups who lack easy access to the advanced liver and critical care services they need.
Ultimately, this analysis serves as a clear signal that the intersection of liver disease and severe infection is a growing public health challenge. The study emphasizes that recognizing infection early in patients with liver disease is critical, as is ensuring that everyone, regardless of where they live or their background, has equitable access to the specialists who can treat them. While the data cannot pinpoint the exact cause for every individual death, the national trends are undeniable. The rising numbers indicate that without targeted interventions to improve early detection, streamline referrals to specialized care, and address the social factors that leave rural and minority populations behind, the burden of these preventable deaths will likely continue to weigh heavily on the nation.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.